The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Animal Antibacterial Peptide-Global Market Insights and Sales Trends 2025
Synopsis
Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and animals are stored in database. The antibacterial peptides are broad spectrum in activity. The antibacterial peptides are amphipathic in structure and contains positive charge.
The global Animal Antibacterial Peptide market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Animal Antibacterial Peptide in various end use industries. The expanding demands from the Poultry and Livestock, are propelling Animal Antibacterial Peptide market. Anionic Peptides, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cationic Peptide segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 177%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Antibacterial Peptide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Antibacterial Peptide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Antibacterial Peptide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Antibacterial Peptide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Antibacterial Peptide covered in this report include Merial, Zoetis, Bayer HealthCare, Merck Animal Health, Elanco (Eli Lilly and Company), Biogenesis Bago, Animal Medics and Boehringer Ingelheim Vetmedica, etc.
The global Animal Antibacterial Peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merial
Zoetis
Bayer HealthCare
Merck Animal Health
Elanco (Eli Lilly and Company)
Biogenesis Bago
Animal Medics
Boehringer Ingelheim Vetmedica
Global Animal Antibacterial Peptide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Antibacterial Peptide market, Segment by Type:
Anionic Peptides
Cationic Peptide
Global Animal Antibacterial Peptide market, by Application
Poultry
Livestock
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Animal Antibacterial Peptide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Animal Antibacterial Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and animals are stored in database. The antibacterial peptides are broad spectrum in activity. The antibacterial peptides are amphipathic in structure and contains positive charge.
The global Animal Antibacterial Peptide market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Animal Antibacterial Peptide in various end use industries. The expanding demands from the Poultry and Livestock, are propelling Animal Antibacterial Peptide market. Anionic Peptides, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cationic Peptide segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 177%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Antibacterial Peptide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Antibacterial Peptide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Antibacterial Peptide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Antibacterial Peptide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Antibacterial Peptide covered in this report include Merial, Zoetis, Bayer HealthCare, Merck Animal Health, Elanco (Eli Lilly and Company), Biogenesis Bago, Animal Medics and Boehringer Ingelheim Vetmedica, etc.
The global Animal Antibacterial Peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merial
Zoetis
Bayer HealthCare
Merck Animal Health
Elanco (Eli Lilly and Company)
Biogenesis Bago
Animal Medics
Boehringer Ingelheim Vetmedica
Global Animal Antibacterial Peptide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Antibacterial Peptide market, Segment by Type:
Anionic Peptides
Cationic Peptide
Global Animal Antibacterial Peptide market, by Application
Poultry
Livestock
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Animal Antibacterial Peptide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Animal Antibacterial Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Animal Antibacterial Peptide Market Overview
1.1 Animal Antibacterial Peptide Product Overview
1.2 Animal Antibacterial Peptide Market Segment by Type
1.2.1 Anionic Peptides
1.2.2 Cationic Peptide
1.3 Global Animal Antibacterial Peptide Market Size by Type
1.3.1 Global Animal Antibacterial Peptide Market Size Overview by Type (2018-2029)
1.3.2 Global Animal Antibacterial Peptide Historic Market Size Review by Type (2018-2023)
1.3.3 Global Animal Antibacterial Peptide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Animal Antibacterial Peptide Sales Breakdown by Type (2018-2023)
1.4.2 Europe Animal Antibacterial Peptide Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Animal Antibacterial Peptide Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Animal Antibacterial Peptide Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Animal Antibacterial Peptide Sales Breakdown by Type (2018-2023)
2 Global Animal Antibacterial Peptide Market Competition by Company
2.1 Global Top Players by Animal Antibacterial Peptide Sales (2018-2023)
2.2 Global Top Players by Animal Antibacterial Peptide Revenue (2018-2023)
2.3 Global Top Players by Animal Antibacterial Peptide Price (2018-2023)
2.4 Global Top Manufacturers Animal Antibacterial Peptide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Animal Antibacterial Peptide Market Competitive Situation and Trends
2.5.1 Animal Antibacterial Peptide Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Animal Antibacterial Peptide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal Antibacterial Peptide as of 2022)
2.7 Date of Key Manufacturers Enter into Animal Antibacterial Peptide Market
2.8 Key Manufacturers Animal Antibacterial Peptide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Animal Antibacterial Peptide Status and Outlook by Region
3.1 Global Animal Antibacterial Peptide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Animal Antibacterial Peptide Historic Market Size by Region
3.2.1 Global Animal Antibacterial Peptide Sales in Volume by Region (2018-2023)
3.2.2 Global Animal Antibacterial Peptide Sales in Value by Region (2018-2023)
3.2.3 Global Animal Antibacterial Peptide Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Animal Antibacterial Peptide Forecasted Market Size by Region
3.3.1 Global Animal Antibacterial Peptide Sales in Volume by Region (2024-2029)
3.3.2 Global Animal Antibacterial Peptide Sales in Value by Region (2024-2029)
3.3.3 Global Animal Antibacterial Peptide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Animal Antibacterial Peptide by Application
4.1 Animal Antibacterial Peptide Market Segment by Application
4.1.1 Poultry
4.1.2 Livestock
4.2 Global Animal Antibacterial Peptide Market Size by Application
4.2.1 Global Animal Antibacterial Peptide Market Size Overview by Application (2018-2029)
4.2.2 Global Animal Antibacterial Peptide Historic Market Size Review by Application (2018-2023)
4.2.3 Global Animal Antibacterial Peptide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Animal Antibacterial Peptide Sales Breakdown by Application (2018-2023)
4.3.2 Europe Animal Antibacterial Peptide Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Animal Antibacterial Peptide Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Animal Antibacterial Peptide Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Animal Antibacterial Peptide Sales Breakdown by Application (2018-2023)
5 North America Animal Antibacterial Peptide by Country
5.1 North America Animal Antibacterial Peptide Historic Market Size by Country
5.1.1 North America Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Animal Antibacterial Peptide Sales in Volume by Country (2018-2023)
5.1.3 North America Animal Antibacterial Peptide Sales in Value by Country (2018-2023)
5.2 North America Animal Antibacterial Peptide Forecasted Market Size by Country
5.2.1 North America Animal Antibacterial Peptide Sales in Volume by Country (2024-2029)
5.2.2 North America Animal Antibacterial Peptide Sales in Value by Country (2024-2029)
6 Europe Animal Antibacterial Peptide by Country
6.1 Europe Animal Antibacterial Peptide Historic Market Size by Country
6.1.1 Europe Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Animal Antibacterial Peptide Sales in Volume by Country (2018-2023)
6.1.3 Europe Animal Antibacterial Peptide Sales in Value by Country (2018-2023)
6.2 Europe Animal Antibacterial Peptide Forecasted Market Size by Country
6.2.1 Europe Animal Antibacterial Peptide Sales in Volume by Country (2024-2029)
6.2.2 Europe Animal Antibacterial Peptide Sales in Value by Country (2024-2029)
7 Asia-Pacific Animal Antibacterial Peptide by Region
7.1 Asia-Pacific Animal Antibacterial Peptide Historic Market Size by Region
7.1.1 Asia-Pacific Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Animal Antibacterial Peptide Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Animal Antibacterial Peptide Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Animal Antibacterial Peptide Forecasted Market Size by Region
7.2.1 Asia-Pacific Animal Antibacterial Peptide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Animal Antibacterial Peptide Sales in Value by Region (2024-2029)
8 Latin America Animal Antibacterial Peptide by Country
8.1 Latin America Animal Antibacterial Peptide Historic Market Size by Country
8.1.1 Latin America Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Animal Antibacterial Peptide Sales in Volume by Country (2018-2023)
8.1.3 Latin America Animal Antibacterial Peptide Sales in Value by Country (2018-2023)
8.2 Latin America Animal Antibacterial Peptide Forecasted Market Size by Country
8.2.1 Latin America Animal Antibacterial Peptide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Animal Antibacterial Peptide Sales in Value by Country (2024-2029)
9 Middle East and Africa Animal Antibacterial Peptide by Country
9.1 Middle East and Africa Animal Antibacterial Peptide Historic Market Size by Country
9.1.1 Middle East and Africa Animal Antibacterial Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Animal Antibacterial Peptide Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Animal Antibacterial Peptide Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Animal Antibacterial Peptide Forecasted Market Size by Country
9.2.1 Middle East and Africa Animal Antibacterial Peptide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Animal Antibacterial Peptide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merial
10.1.1 Merial Company Information
10.1.2 Merial Introduction and Business Overview
10.1.3 Merial Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merial Animal Antibacterial Peptide Products Offered
10.1.5 Merial Recent Development
10.2 Zoetis
10.2.1 Zoetis Company Information
10.2.2 Zoetis Introduction and Business Overview
10.2.3 Zoetis Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Zoetis Animal Antibacterial Peptide Products Offered
10.2.5 Zoetis Recent Development
10.3 Bayer HealthCare
10.3.1 Bayer HealthCare Company Information
10.3.2 Bayer HealthCare Introduction and Business Overview
10.3.3 Bayer HealthCare Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bayer HealthCare Animal Antibacterial Peptide Products Offered
10.3.5 Bayer HealthCare Recent Development
10.4 Merck Animal Health
10.4.1 Merck Animal Health Company Information
10.4.2 Merck Animal Health Introduction and Business Overview
10.4.3 Merck Animal Health Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck Animal Health Animal Antibacterial Peptide Products Offered
10.4.5 Merck Animal Health Recent Development
10.5 Elanco (Eli Lilly and Company)
10.5.1 Elanco (Eli Lilly and Company) Company Information
10.5.2 Elanco (Eli Lilly and Company) Introduction and Business Overview
10.5.3 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Products Offered
10.5.5 Elanco (Eli Lilly and Company) Recent Development
10.6 Biogenesis Bago
10.6.1 Biogenesis Bago Company Information
10.6.2 Biogenesis Bago Introduction and Business Overview
10.6.3 Biogenesis Bago Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Biogenesis Bago Animal Antibacterial Peptide Products Offered
10.6.5 Biogenesis Bago Recent Development
10.7 Animal Medics
10.7.1 Animal Medics Company Information
10.7.2 Animal Medics Introduction and Business Overview
10.7.3 Animal Medics Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Animal Medics Animal Antibacterial Peptide Products Offered
10.7.5 Animal Medics Recent Development
10.8 Boehringer Ingelheim Vetmedica
10.8.1 Boehringer Ingelheim Vetmedica Company Information
10.8.2 Boehringer Ingelheim Vetmedica Introduction and Business Overview
10.8.3 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Products Offered
10.8.5 Boehringer Ingelheim Vetmedica Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Animal Antibacterial Peptide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Animal Antibacterial Peptide Industrial Chain Analysis
11.4 Animal Antibacterial Peptide Market Dynamics
11.4.1 Animal Antibacterial Peptide Industry Trends
11.4.2 Animal Antibacterial Peptide Market Drivers
11.4.3 Animal Antibacterial Peptide Market Challenges
11.4.4 Animal Antibacterial Peptide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Animal Antibacterial Peptide Distributors
12.3 Animal Antibacterial Peptide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
